Fluoxetine's effect on weight loss in obese subjects

Open Access
Publisher Website
Google Scholar
Abstract
Forty-five obese subjects with a mean weight of 102.9 kg and a body mass index (in kg/m2) of 37.6 were randomly assigned to a fluoxetine-diet group (n = 23) or a placebo-diet group (n = 22) for 52 wk. At week 29, 14 subjects on fluoxetine who completed the study attained their maximum weight loss of 12.4 kg, an amount significantly greater than the maximum weight loss of 4.5 kg for the 16 on placebo who completed the study. The fluoxetine group's significantly greater mean weight loss continued through week 45. However, those on fluoxetine regained a mean of 4.2 kg from their lowest weight (P < 0.001 ) whereas the placebo group did not. By the end of the study, each group weighed significantly less than they did at baseline (fluoxetine: −8.2 kg; placebo: −4.5 kg; P < 0.05) although the difference between groups was no longer significant (P > 0.05). Several factors were considered as possible causes for the regain with fluoxetine.